Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military

Journal of Acquired Immune Deficiency Syndromes

Volumn 27, Issue 4, 2001, Pages 381-388

  McGrath, Janet W ^a   George, Kathleen ^b   Svilar, Grace ^c   Ihler, Elizabeth ^a   Mafigiri, David ^d   Kabugo, Michael ^e   Mugisha, Emmanuel ^f  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b FAMILY HEALTH INTERNATIONAL   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDICAL RESEARCH COUNCIL   (Uganda)

^e National Social Security Fund   (Uganda)

^f JOINT CLINICAL RESEARCH CENTRE   (Uganda)

Author keywords

HIV vaccine trials; Informed consent; Uganda; Willingness to participate

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; DATA ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MILITARY SERVICE; MOTIVATION; PATIENT EDUCATION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; UGANDA;

EID: 0035424510     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200108010-00009     Document Type: Article

References (29)

1. Patients' attitudes to participation in clinical trials
2. Attitudes toward clinical trials among patients and the public
3. Patients' willingness to enter clinical trials: Measuring the association with perceived benefit and preference for decision participation
4. Participation in a clinical trial: The patients' point of view
5. Behavioral studies relevant to vaccine trial preparation: An introduction
6. Behavioral research contributions to planning and conducting HIV vaccine efficacy studies
7. Participation of homosexual/bisexual men in preventive HIV vaccine trials: Baseline attitudes and concerns and predicted behaviors during trials
8. The decision to enroll in HIV vaccine efficacy trials: Concerns elicited from gay men at increased risk for HIV infection
9. Interest in HIV vaccines among injection drug users in Baltimore, MD
10. Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya
11. Risk behavior for HIV infection in participants in preventive HIV vaccine trials: A cautionary note
12. HIV-1 risk and vaccine acceptability in the Ugandan military
13. Willingness to participate in AIDS vaccine trials among high risk populations in northern Thailand
14. Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers
15. Safety, immunity, and risk behavior in HIV-1 uninfected volunteers representing diverse risk populations following recombinant envelope vaccinations: A three year follow up
16. Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men
17. Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in the New York City: Project ACHIEVE
18. A factorial survey study to assess the acceptability of HIV vaccine trial designs
19. Willingness to volunteer in future preventive HIV vaccine trials: Issues and perspectives from three U.S. communities
20. Involving women in HIV vaccine efficacy trials: Lessons learned from a vaccine preparedness study in New York City
21. Hepatitis B: A potential incentive to HIV vaccine trial participation in Thailand?
22. Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trials in Thailand
23. HIV vaccine trials: Will intravenous drug users enroll?
24. Risk for HIV-1 seroconversion in the Ugandan Peoples Defense Forces
25. Preparation for AIDS vaccine trials in the Ugandan military
26. Developing aids vaccine trials education programs in Uganda
27. Practical experiences in obtaining informed consent for a vaccine trial in rural Africa
28. Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand
29. Cultural feasibility studies in preparation for clinical trials to reduce maternal-infant HIV transmission in Haiti